×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CDXS – codexis, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CDXS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/25
09:00 am
cdxs
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11
Low
Report
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11
2/17
09:00 am
cdxs
Codexis to Participate in TD Cowen 46th Annual Health Care Conference
Low
Report
Codexis to Participate in TD Cowen 46th Annual Health Care Conference
2/10
09:00 am
cdxs
Codexis Achieves ISO 9001:2015 Certification
Medium
Report
Codexis Achieves ISO 9001:2015 Certification
1/7
09:00 am
cdxs
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics
Medium
Report
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics
1/7
09:00 am
cdxs
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics
Medium
Report
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics
12/12
04:19 pm
cdxs
Codexis' ECO Synthesis® Manufacturing Platform: Transforming RNA Therapeutics [CBS News]
Low
Report
Codexis' ECO Synthesis® Manufacturing Platform: Transforming RNA Therapeutics [CBS News]
12/4
12:06 am
cdxs
Codexis' ECO Synthesis® Manufacturing Platform: Transforming RNA Therapeutics [CBS News]
Medium
Report
Codexis' ECO Synthesis® Manufacturing Platform: Transforming RNA Therapeutics [CBS News]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/23
08:09 pm
cdxs
Form 144 CODEXIS, INC. Filed by: Lutz Stefan
Low
Report
Form 144 CODEXIS, INC. Filed by: Lutz Stefan
2/9
04:07 pm
cdxs
Form 4 CODEXIS, INC. For: Feb 06 Filed by: Erbez Georgia
Medium
Report
Form 4 CODEXIS, INC. For: Feb 06 Filed by: Erbez Georgia
2/9
04:07 pm
cdxs
Form 4 CODEXIS, INC. For: Feb 06 Filed by: Lutz Stefan
Medium
Report
Form 4 CODEXIS, INC. For: Feb 06 Filed by: Lutz Stefan
2/9
04:06 pm
cdxs
Form 4 CODEXIS, INC. For: Feb 06 Filed by: MOORE ALISON
Medium
Report
Form 4 CODEXIS, INC. For: Feb 06 Filed by: MOORE ALISON
2/6
06:18 pm
cdxs
Form 144 CODEXIS, INC. Filed by: Norrett Kevin
Medium
Report
Form 144 CODEXIS, INC. Filed by: Norrett Kevin
2/6
06:16 pm
cdxs
Form 144 CODEXIS, INC. Filed by: Lutz Stefan
Medium
Report
Form 144 CODEXIS, INC. Filed by: Lutz Stefan
1/23
04:05 pm
cdxs
Form SCHEDULE 13G/A CODEXIS, INC. Filed by: Opaleye Management Inc.
Medium
Report
Form SCHEDULE 13G/A CODEXIS, INC. Filed by: Opaleye Management Inc.
1/16
05:10 pm
cdxs
Form 144 CODEXIS, INC. Filed by: Norrett Kevin
Medium
Report
Form 144 CODEXIS, INC. Filed by: Norrett Kevin
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/23
Codexis, Inc. (NASDAQ: CDXS) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.
12.1%
3/23 Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders 11.0%
11/5 Q3/2019 9/30/2019 EPS 0.040 ZacksConsensus -0.090 ActVsEst 0.130 - Beat 9.4%
8/26 Form 4 CODEXIS, INC. For: Aug 22 Filed by: Yang Patrick Y 7.7%
4/3 Form 4 CODEXIS, INC. For: Apr 01 Filed by: BARUCH THOMAS R 6.6%
3/27 Form 4 CODEXIS, INC. For: Mar 25 Filed by: WOLF DENNIS P 5.7%
3/4 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.6%
3/5 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.8%
4/8 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 4.3%
9/4 Form 4 CODEXIS, INC. For: Sep 03 Filed by: Yang Patrick Y 3.6%
3/23 Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders 11.0%
11/5 Q3/2019 9/30/2019 EPS 0.040 ZacksConsensus -0.090 ActVsEst 0.130 - Beat 9.4%
8/26 Form 4 CODEXIS, INC. For: Aug 22 Filed by: Yang Patrick Y 7.7%
4/3 Form 4 CODEXIS, INC. For: Apr 01 Filed by: BARUCH THOMAS R 6.6%
3/27 Form 4 CODEXIS, INC. For: Mar 25 Filed by: WOLF DENNIS P 5.7%
3/4 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.6%
3/5 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.8%
4/8 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 4.3%
9/4 Form 4 CODEXIS, INC. For: Sep 03 Filed by: Yang Patrick Y 3.6%
TOP News Decliners
8/6
Form 10-Q CODEXIS, INC. For: Jun 30
-18.3%
2/28 Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.50 price target on the stock. -12.2%
5/7 Codexis, Inc. (CDXS) CEO John Nicols on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -8.2%
4/15 Near a 2-Year Low, Is Codexis Stock a Buy? [The Motley Fool] -7.1%
5/10 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -6.5%
12/24 Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.50 price target on the stock. -5.2%
2/25 Codexis to Present at Two Investment Conferences in March -4.1%
5/22 Codexis (CDXS) Presents At UBS Global Healthcare Conference - Slideshow [Seeking Alpha] -3.9%
4/23 Form 4 CODEXIS, INC. For: Apr 21 Filed by: KELLEY BERNARD J -3.6%
7/23 Form 8-K CODEXIS, INC. For: Jul 19 -3.5%
2/28 Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.50 price target on the stock. -12.2%
5/7 Codexis, Inc. (CDXS) CEO John Nicols on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -8.2%
4/15 Near a 2-Year Low, Is Codexis Stock a Buy? [The Motley Fool] -7.1%
5/10 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -6.5%
12/24 Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.50 price target on the stock. -5.2%
2/25 Codexis to Present at Two Investment Conferences in March -4.1%
5/22 Codexis (CDXS) Presents At UBS Global Healthcare Conference - Slideshow [Seeking Alpha] -3.9%
4/23 Form 4 CODEXIS, INC. For: Apr 21 Filed by: KELLEY BERNARD J -3.6%
7/23 Form 8-K CODEXIS, INC. For: Jul 19 -3.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: